There was also an issue of them marketing it as a twice a day drug, which would create big swings for users that fostered addiction. http://www.latimes.com/pro

There was also an issue of them marketing it as a twice a day drug, which would create big swings for users that fostered addiction. http://www.latimes.com/projects/oxycontin-part1/ http://www.latimes.com/projects/oxycontin-part1/